In a regulatory filing, Paratek Pharmaceuticals disclosed that James Dondero of Highland Capital Management bought 788.5K shares of common stock on March 17th in a total transaction size of $1.3M.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on PRTK:
- Paratek Pharmaceuticals rumor mentioned by Betaville
- Paratek price target lowered to $10 from $20 at H.C. Wainwright
- Paratek Pharmaceuticals Announces Full-Year 2022 Revenue of $160.3 Million
- Paratek Pharmaceuticals sees FY23 revenue $143M-$158M, consensus $232.02M
- Paratek Pharmaceuticals reports Q4 EPS (13c), consensus 9c